Last Updated: June 22, 2026

DOPAMINE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Dopamine, and when can generic versions of Dopamine launch?

Dopamine is a drug marketed by Abbott, Abraxis Pharm, Am Regent, Baxter Hlthcare, Hikma Intl Pharms, Hospira, Igi Labs Inc, Intl Medication, Lyphomed, Smith And Nephew, Teligent, Teva Parenteral, Warner Chilcott, and B Braun. and is included in thirty-six NDAs.

The generic ingredient in DOPAMINE is dopamine hydrochloride. There are nine drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the dopamine hydrochloride profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Dopamine

A generic version of DOPAMINE was approved as dopamine hydrochloride by HOSPIRA on February 4th, 1982.

  Start Trial

AI Deep Research
Questions you can ask:
  • What is the 5 year forecast for DOPAMINE?
  • What are the global sales for DOPAMINE?
  • What is Average Wholesale Price for DOPAMINE?
Summary for DOPAMINE
US Patents:0
Applicants:14
NDAs:36
Drug Prices: Drug price information for DOPAMINE
DailyMed Link:DOPAMINE at DailyMed

US Patents and Regulatory Information for DOPAMINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
B Braun DOPAMINE HYDROCHLORIDE AND DEXTROSE 5% IN PLASTIC CONTAINER dopamine hydrochloride INJECTABLE;INJECTION 019099-003 Oct 15, 1986 DISCN Yes No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Teligent DOPAMINE HYDROCHLORIDE dopamine hydrochloride INJECTABLE;INJECTION 018656-001 Jun 28, 1983 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Hospira DOPAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER dopamine hydrochloride INJECTABLE;INJECTION 018826-003 Sep 30, 1983 AP RX Yes Yes ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Baxter Hlthcare DOPAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER dopamine hydrochloride INJECTABLE;INJECTION 019615-003 Mar 27, 1987 AP RX Yes Yes ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.